Profile data is unavailable for this security.
About the company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
- Revenue in CHF (TTM)0.00
- Net income in CHF-60.24m
- Incorporated2004
- Employees153.00
- LocationMolecular Partners AGWagistrasse 14SCHLIEREN 8952SwitzerlandCHE
- Phone+41 447557700
- Fax+41 447557707
- Websitehttps://www.molecularpartners.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abionyx Pharma SA | 3.94m | -4.19m | 115.99m | 51.00 | -- | 22.66 | -- | 29.43 | -0.1317 | -0.1317 | 0.1238 | 0.1582 | 0.3033 | 17.39 | 7.16 | 84,823.53 | -32.25 | -26.53 | -43.11 | -38.31 | 17.78 | 15.59 | -106.31 | -131.06 | 1.35 | -- | 0.4281 | -- | -1.92 | -- | -24.53 | -- | -- | -- |
| Xlife Sciences AG | 839.38k | 30.75m | 118.24m | 17.00 | 5.03 | 0.3879 | 2.87 | 140.86 | 4.08 | 4.08 | 0.1284 | 52.84 | 0.0016 | -- | 0.0907 | 49,375.29 | 4.80 | 6.01 | 5.95 | 7.37 | 62.17 | 37.44 | 2,991.34 | 2,987.92 | 1.07 | -- | 0.131 | -- | -15.54 | 10.15 | 130.37 | 100.79 | -13.48 | -- |
| Nightingale Health Oyj | 4.28m | -16.82m | 124.15m | 100.00 | -- | 1.53 | -- | 29.04 | -0.3052 | -0.3052 | 0.0778 | 1.10 | 0.0568 | 0.9444 | 2.79 | 46,930.00 | -22.33 | -15.66 | -24.26 | -16.95 | 75.39 | 75.21 | -393.39 | -447.17 | 8.52 | -- | 0.0511 | -- | 7.69 | 21.38 | -5.71 | -- | -12.69 | -- |
| Innate Pharma SA | 5.47m | -41.96m | 125.38m | 181.00 | -- | 26.30 | -- | 22.94 | -0.5497 | -0.5497 | 0.0714 | 0.0558 | 0.0491 | -- | 15.81 | 33,149.17 | -37.68 | -13.19 | -52.10 | -17.17 | 49.52 | 91.15 | -767.52 | -88.46 | -- | -- | 0.8401 | -- | -75.68 | -28.80 | -553.51 | -- | -64.08 | -- |
| Ryvu Therapeutics SA | 15.10m | -25.68m | 125.80m | 294.00 | -- | 8.16 | -- | 8.33 | -5.13 | -5.13 | 3.02 | 3.08 | 0.212 | 12.29 | 7.31 | 237,411.60 | -36.05 | -23.64 | -48.51 | -27.84 | 70.86 | 29.35 | -170.05 | -208.85 | 2.26 | -- | 0.572 | -- | 66.38 | 83.01 | -20.98 | -- | -24.46 | -- |
| Solar Foods Oyj | 17.41k | -9.72m | 127.96m | 57.00 | -- | 6.61 | -- | 7,349.74 | -0.433 | -0.433 | 0.0008 | 0.7115 | 0.0004 | -- | 0.0037 | 455.00 | -22.45 | -- | -27.05 | -- | 25,931.57 | -- | -55,808.37 | -- | -- | -7.03 | 0.5092 | -- | 275.15 | -- | -22.57 | -- | -- | -- |
| Heidelberg Pharma AG | 2.77m | -23.85m | 129.58m | 114.00 | -- | 13.51 | -- | 46.82 | -0.558 | -0.558 | 0.0647 | 0.2251 | 0.0507 | 0.0329 | 69.14 | 28,928.10 | -43.69 | -40.90 | -50.29 | -58.51 | 84.66 | 55.95 | -861.83 | -228.64 | 3.55 | -- | 0.7766 | -- | -30.53 | -1.29 | 4.74 | -- | -13.09 | -- |
| Maat Pharma SA | 3.57m | -28.36m | 133.43m | 60.00 | -- | 15.13 | -- | 37.34 | -2.15 | -2.15 | 0.270 | 0.5141 | 0.0786 | 11.22 | 0.5785 | 65,366.67 | -62.39 | -41.51 | -90.20 | -51.87 | 61.68 | -- | -793.83 | -976.99 | 2.21 | -29.53 | 0.6346 | -- | 44.34 | -- | -46.59 | -- | 42.53 | -- |
| Intellego Technologies AB | 66.32m | 25.35m | 133.59m | 65.00 | 4.75 | 2.33 | 4.81 | 2.01 | 9.81 | 9.81 | 25.91 | 20.01 | 1.28 | 10.59 | 2.32 | 12,432,400.00 | 49.11 | 17.13 | 61.64 | 23.87 | 70.97 | 58.82 | 38.23 | 21.32 | 4.11 | 5.35 | 0.0617 | -- | 42.25 | 222.71 | 14.78 | -- | -- | -- |
| BioVersys AG | -100.00bn | -100.00bn | 135.67m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.28 | -- | -- | -- |
| Molecular Partners AG | 0.00 | -60.24m | 137.68m | 153.00 | -- | 1.34 | -- | -- | -1.63 | -1.63 | 0.00 | 2.55 | 0.00 | -- | -- | 0.00 | -45.23 | -13.09 | -49.34 | -15.66 | -- | 99.25 | -- | -56.51 | -- | -- | 0.0158 | -- | -29.38 | -24.59 | 12.81 | -- | -17.26 | -- |
| Thor Medical ASA | 8.08k | -4.76m | 146.22m | 13.00 | -- | 3.77 | -- | 18,093.33 | -0.223 | -0.223 | 0.0004 | 1.36 | 0.0002 | -- | 0.0078 | 11,111.11 | -13.37 | -59.74 | -13.90 | -81.16 | -- | -- | -58,908.00 | -- | 8.78 | -- | 0.018 | -- | -- | -- | -659.00 | -- | -33.37 | -- |
| BioInvent International AB | 21.07m | -27.87m | 146.91m | 124.00 | -- | 2.50 | -- | 6.97 | -4.91 | -4.91 | 3.72 | 10.38 | 0.2614 | -- | 4.90 | 2,147,790.00 | -34.58 | -19.38 | -38.20 | -20.57 | -- | -- | -132.30 | -189.97 | 7.31 | -- | 0.0154 | -- | -37.47 | -13.77 | -29.99 | -- | 21.19 | -- |
| Devyser Diagnostics AB | 20.89m | -2.17m | 147.00m | 115.00 | -- | 5.01 | 1,220.48 | 7.04 | -1.52 | -1.52 | 14.66 | 20.48 | 0.5262 | 1.40 | 5.53 | 1,839,394.00 | -5.64 | -10.61 | -6.60 | -12.04 | 81.96 | 80.33 | -10.71 | -28.67 | 2.27 | -2.03 | 0.1312 | -- | 28.12 | 27.53 | -14.74 | -- | 52.54 | -- |
| Scancell Holdings Plc | 4.94m | -5.77m | 152.23m | 60.00 | -- | -- | -- | 30.84 | -0.0053 | -0.0053 | 0.0047 | -0.0081 | 0.2946 | -- | 8.26 | 78,516.66 | -34.46 | -33.29 | -- | -44.23 | 94.95 | -- | -116.98 | -502.03 | -- | -- | 2.07 | -- | -- | -- | -109.46 | -- | 124.48 | -- |
| Sensorion SA | 0.00 | -25.59m | 158.58m | 68.00 | -- | 1.78 | -- | -- | -0.0931 | -0.0931 | 0.00 | 0.1895 | 0.00 | -- | -- | 0.00 | -32.12 | -34.53 | -38.36 | -43.50 | -- | -- | -- | -- | -- | -- | 0.0265 | -- | -- | -- | -17.72 | -- | 98.90 | -- |
Data as of Feb 16 2026. Currency figures normalised to Molecular Partners AG's reporting currency: Swiss Franc CHF
30.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BVF Partners LPas of 25 Oct 2024 | 8.53m | 21.14% |
| UBS Asset Management Switzerland AGas of 19 Dec 2025 | 2.05m | 5.09% |
| GAM Investment Management (Switzerland) AGas of 31 Mar 2025 | 989.70k | 2.45% |
| Z�rcher Kantonalbank (Investment Management)as of 31 Dec 2025 | 334.24k | 0.83% |
| Pictet Asset Management SAas of 31 Oct 2025 | 143.94k | 0.36% |
| Zenito Oyas of 30 Dec 2025 | 123.95k | 0.31% |
| BlackRock Asset Management Deutschland AGas of 05 Feb 2026 | 97.15k | 0.24% |
| LLB Asset Management AGas of 31 Dec 2025 | 63.01k | 0.16% |
| Migros Bank AGas of 30 Jun 2025 | 46.33k | 0.12% |
| Swiss Life Asset Management AGas of 30 Sep 2025 | 36.84k | 0.09% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
